Announced Wed, 15 Jul · 17:08 IST
Compliance Certificate under Regulation 74(5) of SEBI DP Regulations for Q1 FY27
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve
Awaiting price reaction for this filing.
AI summary
Link Pharma Chem submitted a compliance certificate under SEBI Regulation 74(5) for the quarter ended 30 June 2026. MUFG Intime India, the company's Registrar and Share Transfer Agent, confirmed that securities received for dematerialisation during the quarter were properly processed, listed on the exchanges, and reflected in depository records within prescribed timelines. This is a routine procedural filing.
Likely market impact
Routine procedural compliance filing with no material impact on shareholders or stock price.